Trial Profile
A Double-Blind, 9-Week Extension Study Evaluating the Safety and Maintenance of Effect of Asenapine vs. Olanzapine in the Treatment of Subjects With Acute Mania Clinical Trial Protocol A7501006 (Secondary Title: ARES)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Feb 2022
Price :
$35
*
At a glance
- Drugs Asenapine (Primary) ; Olanzapine
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme; Organon
- 06 Jun 2017 New trial record